- Home
- / Pharmerica
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Pharmerica financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$2.1 B
FY, 2016
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|---|---|
| Revenue | 2.1B | 1.8B | 1.8B | 1.9B | 2.0B | 2.1B |
| Revenue growth, % | 7.8% | 7.1% | 3.1% | |||
| Cost of goods sold | 1.8B | 1.5B | 1.4B | 1.6B | 1.7B | 1.8B |
| Gross profit | 293.3M | 300.2M | 327.2M | 339.3M | 335.1M | 326.0M |
| Gross profit margin, % | 14.1% | 16.4% | 18.6% | 17.9% | 16.5% | 15.6% |
| General and administrative expense | 214.9M | 214.7M | 225.3M | 236.3M | 222.5M | 220.6M |
| Operating expense total | 246.3M | 251.4M | 271.4M | 308.9M | 281.3M | 287.6M |
| Depreciation and amortization | 15.4M | 20.1M | 28.6M | 33.7M | ||
| EBIT | 47.0M | 48.8M | 55.8M | 30.4M | 53.8M | 38.4M |
| EBIT margin, % | 2.3% | 2.7% | 3.2% | 1.6% | 2.7% | 1.8% |
| Interest expense | 8.8M | 10.0M | 10.6M | 9.9M | 6.6M | 9.5M |
| Pre tax profit | 38.2M | 38.8M | 45.2M | 16.2M | 47.2M | 28.9M |
| Income tax expense | 14.8M | 15.9M | 26.3M | 9.4M | 12.1M | 7.3M |
| Net Income | 23.4M | 22.9M | 18.9M | 6.8M | 35.1M | 21.6M |